How AI and a Menopause Drug Could Revolutionize Breast Cancer Prevention

Episode Summary: Breast Cancer Prevention Just Took Two Big Steps Forward

In this short but powerful episode, Georgie breaks down two groundbreaking developments in breast cancer prevention that could reshape how we think about screening, menopause care, and early intervention:

1️⃣ An FDA-authorized AI tool—Clairity Breast—that predicts a woman’s five-year breast cancer risk from a standard mammogram, even when it appears normal.

2️⃣ A menopause drug, Duavee, that may help prevent invasive breast cancer in women with a history of high-risk lesions like DCIS.

These tools aren’t just high-tech—they’re practical, accessible, and represent a smarter, more equitable approach to women’s health.

Whether you're a clinician, policymaker, or woman navigating your own care, this episode breaks down what you need to know.

🔍 What You'll Learn in This Episode

✅ FDA-Approved AI for Breast Cancer Risk Prediction

• What Clairity Breast is and how it works
• Why it matters for women under 50
• How it fits into current mammogram workflows
• Timeline for rollout and insurance coverage considerations

✅ Menopause Drug Duavee and Breast Cancer Prevention

• New clinical trial results shared at the ASCO 2025 meeting
• Why this treatment could benefit women with DCIS or other precancerous lesions
• What clinicians and high-risk patients should be asking now
• Duavee’s current FDA status and reimbursement landscape

✅ The Bigger Picture: Why This Is a Turning Point in Women's Health

• What these two tools signal about the future of precision and prevention
• How they're designed to work in real-world care—not just research labs
• Why this episode matters for people advocating for smarter, faster, fairer care

🎯 Who This Episode Is For

• Women navigating breast cancer risk or menopause decisions
• Clinicians, radiologists, and OB-GYNs focused on patient-centered care
• Healthcare innovators, startup leaders, and payers interested in smarter early intervention
• Policy leaders and health equity advocates

📌 Resources & References

• Read about Clairity Breast – FDA De Novo authorization details
• Learn about Duavee – Clinical trial results presented at ASCO 2025
• Check out the blog post of this episode: Breast Cancer Prevention Just Leveled Up: What Two Breakthroughs Mean for the Future of Women’s Health

📣 Help Spread the Word

If this episode helped you understand the future of breast cancer prevention, share it with a friend or clinician who needs to hear it.

🎧 Loved the episode? Here's how you can take action:

1. Help others discover Fempower Health:

Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.

2. Stay connected:

Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.

Or join our newsletter to get curated women's health content—on your terms, in your inbox.

**Top 50 Health Podcast of 2024**

**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**